Literature DB >> 11412572

[Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].

R de los Ríos Martín1, N García Marín, J Sanz Moreno, E Ballester Orcal.   

Abstract

OBJECTIVES: To describe the epidemiological situation of an epidemic of mumps, to calculate the risk of catching the illness depending on the vaccine strain used and to evaluate the diagnostic performance of the serologic determination.
DESIGN: Longitudinal observational study. The incidence of mumps between January 1999 and June 2000 was calculated. Case-control study of outbreaks evaluated the risk of catching the disease depending on the vaccine strain.
SETTING: Health Area 4 in the Community of Madrid. PARTICIPANTS: Residents and students from schools in the district.Interventions. Epidemiological vigilance. Serologic determination of IgM and titration of IgG. In outbreaks, people exposed were vaccinated after assessment of their vaccine status.
MEASUREMENTS AND MAIN RESULTS: The rate of incidence in the first 27 weeks of the year 2000 for the 1-4 year-old age group was 334.7/105, against 12.2 in 1999. In children under 5 vaccinated with the Rubini strain there was a significantly greater risk of suffering illness than in those vaccinated with the Jeryl-Lynn strain (OR, 6.28, 95% CI, 1.43-38.50). The amount of cases confirmed serologically (specific IgM positive) was 22.22%. The mean of the logarithms of the IgG titres was significantly higher (p < 0.001) in IgM-negative patients with epidemiological confirmation (4.05, 95% CI, 3.18-4.28) than in IgM-negative cases without any epidemiological link (2.58; 95% CI, 2.33-2.84).
CONCLUSIONS: We emphasise the increase of mumps incidence in the school population (fundamentally in the under-5s), which parallels an increase in outbreaks. The results suggest that the Rubini strain is less efficacious. The possibility of using alternative methods to IgM detection (IgG titration) as a diagnostic tool in a population with high vaccination coverage is posed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412572      PMCID: PMC7681703          DOI: 10.1016/s0212-6567(01)78889-0

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  13 in total

1.  [Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases].

Authors:  J Limón Mora; T Molina López; J C Domínguez Camacho
Journal:  Rev Esp Salud Publica       Date:  1999 Jul-Aug

2.  Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study.

Authors:  M Schlegel; J J Osterwalder; R L Galeazzi; P L Vernazza
Journal:  BMJ       Date:  1999-08-07

3.  Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996.

Authors:  G Goncalves; A De Araujo; M.L. Monteiro Cardoso
Journal:  Euro Surveill       Date:  1998-12

4.  [Is parotiditis preventable in Spain].

Authors:  A Arnedo Pena
Journal:  Med Clin (Barc)       Date:  1992-09-19       Impact factor: 1.725

Review 5.  Immunisation and herd immunity.

Authors:  R M Anderson; R M May
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

6.  A large outbreak of mumps in the postvaccine era.

Authors:  M Wharton; S L Cochi; R H Hutcheson; J M Bistowish; W Schaffner
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  An outbreak of mumps in a population partially vaccinated with the Rubini strain.

Authors:  D Germann; A Ströhle; K Eggenberger; C A Steiner; L Matter
Journal:  Scand J Infect Dis       Date:  1996

8.  Mumps and mumps vaccine: a global review.

Authors:  A M Galazka; S E Robertson; A Kraigher
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

9.  [Parotiditis in postvaccination period. Epidemiologic pattern and vaccine effectiveness in an epidemic outbreak].

Authors:  J Guimbao Bescós; M P Moreno Marín; V Gutiérrez Colás; M R Pac Sá; F Arribas Monzón
Journal:  Med Clin (Barc)       Date:  1992-09-19       Impact factor: 1.725

10.  Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.

Authors:  H C Matter; J Cloetta; H Zimmermann
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.